Use of a pharmaceutically acceptable Agent that removes the hepatitis B surface antigen of blood and a Second Agent that stimulates immune function, to treat hepatitis B Hepatitis B Hepatitis D coinfection or / and composition comprising both agents.

摘要

It is disclosed a method for the treatment of hepatitis B (HBV) infection or HBV/hepatitis D (HDV) co-infection, the method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent that removes the hepatitis B surface antigen from the blood and a second pharmaceutically acceptable agent which stimulates immune function.